Vor Biopharma Inc. (VOR)
NASDAQ: VOR
· Real-Time Price · USD
2.13
0.15 (7.58%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.24%
After-hours: Aug 15, 2025, 07:58 PM EDT
Vor Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 3.69M | n/a | n/a | n/a | 12.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.1M | 825K | n/a | 900K | 900K | 943K | 892K | 2.09M | 1.23M | 2.79M | 3.06M | 2.39M | 575K | 426K | 1.15M | 1.13M | 354K | 633K |
Gross Profit | -2.1M | -825K | 1.84M | -900K | -900K | -943K | 11.33M | -2.09M | -1.23M | -2.79M | -3.06M | -2.39M | -575K | -426K | -1.15M | -1.13M | -354K | -633K |
Operating Income | -274.28M | -33.29M | -31.31M | -28.51M | -29.04M | -32.33M | -28.12M | -35.32M | -32.17M | -30.42M | -24.73M | -24.1M | -21.79M | -22.8M | -18.31M | -18.6M | -18.38M | -13.73M |
Interest Income | 537K | 805K | 599K | 954K | 1.2M | 1.52M | 1.86M | 2.13M | 2.19M | 1.99M | 815K | 313K | 133K | 63K | 54K | 48K | 10K | 7K |
Pretax Income | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M | -13.72M |
Net Income | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -26.44M | -22.9M | -23.48M | -21.53M | -22.67M | -18.25M | -18.55M | -18.37M | -13.72M |
Selling & General & Admin | 12.79M | 6.59M | 5.96M | 6.7M | 6.31M | 7.06M | 6.33M | 7.71M | 8.28M | 8.51M | 7.66M | 7.23M | 6.46M | 7.52M | 5.61M | 5.68M | 5.41M | 4.79M |
Research & Development | 261.5M | 26.7M | 25.35M | 21.82M | 21.82M | 24.32M | 20.9M | 27.61M | 23.9M | 21.91M | 17.06M | 16.88M | 15.33M | 15.28M | 12.69M | 12.93M | 12.97M | 8.94M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 892K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 274.28M | 33.29M | 31.31M | 28.51M | 28.14M | 31.38M | 28.12M | 35.32M | 32.17M | 30.42M | 24.73M | 24.1M | 21.79M | 22.8M | 18.31M | 18.6M | 18.38M | 13.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -900K | -943K | -892K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 274.28M | 33.29M | 31.31M | 28.51M | 29.04M | 32.33M | 28.12M | 35.32M | 32.17M | 30.42M | 24.73M | 24.1M | 21.79M | 22.8M | 18.31M | 18.6M | 18.38M | 13.73M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.99M | -1.01M | -313K | -133K | -63K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 125.27M | 124.82M | 68.71M | 68.47M | 68.3M | 68.03M | 67.89M | 67.61M | 67.03M | 66.27M | 46.5M | 38.01M | 37.44M | 37.29M | 36.93M | 36.93M | 36.84M | 22.26M |
Shares Outstanding (Diluted) | 125.27M | 124.82M | 68.71M | 68.47M | 68.3M | 68.03M | 67.89M | 67.61M | 67.03M | 66.27M | 46.5M | 38.01M | 37.44M | 37.29M | 36.93M | 36.93M | 36.84M | 22.26M |
EPS (Basic) | -12.56 | -0.26 | -0.45 | -0.4 | -0.41 | -0.45 | -0.39 | -0.49 | -0.45 | -0.4 | -0.49 | -0.62 | -0.57 | -0.61 | -0.49 | -0.5 | -0.5 | -0.62 |
EPS (Diluted) | -12.56 | -0.26 | -0.45 | -0.4 | -0.41 | -0.45 | -0.39 | -0.49 | -0.45 | -0.4 | -0.49 | -0.62 | -0.57 | -0.61 | -0.49 | -0.5 | -0.5 | -0.62 |
EBITDA | -274.28M | -33.29M | -30.45M | -27.66M | -28.17M | -31.38M | -27.23M | -34.42M | -31.3M | -29.59M | -24.09M | -23.21M | -21.22M | -22.37M | -17.91M | -18.23M | -18.03M | -13.42M |
EBIT | -1.57B | -33.29M | -31.31M | -28.51M | -29.04M | -32.33M | -28.12M | -35.32M | -32.17M | -30.42M | -24.73M | -24.1M | -21.79M | -22.8M | -18.31M | -18.6M | -18.38M | -13.73M |
Depreciation & Amortization | 2.1M | 825K | 865K | 851K | 869K | 943K | 892K | 893K | 1.23M | 2.79M | 3.06M | 2.39M | 575K | 426K | 1.15M | 1.13M | 354K | 633K |